Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Bad
|
|
New words:
activity, adjust, adjusted, anniversary, anticipate, apparent, arisen, arising, ASC, aware, caption, care, Carlo, Cephalon, charged, chemical, chosen, complexity, consecutive, declared, default, degree, demand, detail, driven, emphasize, experience, explained, exposure, face, facilitate, Flow, force, format, formulation, free, gene, greater, growth, guidance, Hackensack, inherent, Interactive, interim, investor, Irinotecan, Jersey, key, Language, lease, liability, life, low, lower, modify, Monte, observance, OCI, ongoing, overcome, partially, passed, payment, penalty, promotional, proportionate, prospective, readily, recently, reclassification, redeem, redeemable, refocused, reimbursement, Rent, reset, retrospective, revaluation, revaluing, sale, simulation, solution, space, spending, Step, stockholder, strategic, Supplemental, tax, temporary, twelve, underlying, unrelated, volatility, warrant, wording, XBRL, yield
Removed:
acquired, Additionally, administering, allocating, amended, amounted, analog, analyze, approval, approved, approximate, Arizona, arrange, assuming, attributable, award, began, Benzoylyphenylerea, biological, biology, biomarker, Bithionol, BPU, building, Bulletin, category, Chairman, characterization, chemotherapy, closely, collectively, combination, commenced, commercial, commercialize, commitment, compared, comparing, concurrently, conducting, consist, consolidating, consultant, conventional, core, corporate, correspondingly, dependent, deposit, deriving, determination, develop, developmental, directly, earned, enabling, entitled, establishing, evaluating, evenly, evidence, exceed, executed, exempt, exit, expanded, expanding, expansion, expensive, experienced, experimental, facility, faster, federally, formula, generated, genetic, genome, highly, identifiable, identification, impaired, infrastructure, initial, insured, intend, intention, Israeli, January, joint, leading, lesser, leverage, licensed, liquid, lodging, long, maker, manner, market, maturity, meet, member, notice, objective, offering, operation, original, OTC, panel, partner, path, patient, percentage, portfolio, prepaid, primary, procured, procurement, promising, propagation, reached, reaching, realization, receipt, recurring, reduction, reliable, remained, remaining, represented, restoring, satisfaction, scope, seeking, select, sell, selling, service, sixty, soluble, stage, strategy, study, subscription, succeed, sulfur, Tempe, termination, tested, trading, transactivation, transfer, travel, understand, understanding, unregistered, unvested, vaccine, vendor, worldwide, written
Filing tables
Filing exhibits
CSBR similar filings
Filing view
External links
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Champions Biotechnology, Inc. (the “Company”) on Form 10-Q for the period ending July 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. |
| Date: September 13, 2011 | /s/ Joel Ackerman | |
| Joel Ackerman | ||
| Chief Executive Officer (Principal Executive | ||
| Officer) and Acting Principal Financial Officer |